- Report
- November 2025
- 477 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 285 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 384 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 371 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 473 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 374 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 174 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 476 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 471 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 461 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 270 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 470 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 388 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 377 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 268 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 458 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 283 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 469 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 382 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 376 Pages
Global
From €5227EUR$5,850USD£4,608GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more